Reach Separations is a Contract Research Organization (CRO) specializing in outsourced purification services to pharmaceutical, agrochemical, and fine chemical companies throughout the UK and Europe. Based at BioCity in Nottingham in the UK, Reach employs the most advanced liquid chromatography (UPLC), supercritical fluid chromatography (SFC), and mass spectrometry (MS) technologies for the separation, identification, and purification of achiral and chiral small molecules.
The specialty purification services offered by Reach are in increasing demand, particularly so in the pharmaceutical industry, as companies strive to improve the delivery time of compounds to market, while reducing research and development costs, including capital expenditure outlay.
To keep pace with increasing market demand for purification services, Reach has rapidly expanded. Since startup in 2012, Reach has doubled the number of employees, increased lab space 5-fold and invested in new, state-of-the-art instrumentation. In the second year of operation, Reach supported 16 clients all based in the UK. The company now serves more than 90 clients across the UK, mainland Europe and the U.S. and, despite this hectic period of expansion, has succeeded in building an exceptional reputation for quality and timely completion of projects.